Patent · US Active

Nucleic acid-based tests for prenatal gender determination

US8709726B2 · kind B2 · utility

1Cited by

125References

27Claims

0Family size

Assignee

Sequenom, Inc. · US

Inventors

Paul Andrew Oeth · San Diego, US
Payam Mahboubi · San Diego, US
Min Seob Lee · Seongnam-si, KR

Key dates

Filing date	Mar 10, 2009
Grant date	Apr 29, 2014
Priority date	—
Expiry date	Dec 3, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are compositions, processes and kits for noninvasive, early determination of fetal sex from, and/or amount of fetal nucleic acid in, an extracellular nucleic acid sample from a pregnant female. Such compositions, processes and kits are useful for detection of low genomic copy numbers of male fetal nucleic acid in a high copy number background of female nucleic acid, thereby determining the sex of a fetus and/or amount of fetal nucleic acid in a sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.